Axis Capital Holdings Ltd. logo

Axis Capital Holdings Ltd. (AXS)

Market Closed
15 Dec, 20:00
NYSE NYSE
$
106. 38
+2.02
+1.94%
Pre Market
$
113. 10
+6.72 +6.32%
7.87B Market Cap
8.75 P/E Ratio
1.76% Div Yield
369,261 Volume
8.2 Eps
$ 104.36
Previous Close
Day Range
104.44 106.57
Year Range
83.9 107.19
Want to track AXS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 44 days
Here's Why Axis Capital (AXS) is a Strong Value Stock

Here's Why Axis Capital (AXS) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 7 months ago
Here's Why Axis Capital (AXS) is a Strong Momentum Stock

Here's Why Axis Capital (AXS) is a Strong Momentum Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 7 months ago
4 Stocks With Impressive Interest Coverage Ratio to Buy Now

4 Stocks With Impressive Interest Coverage Ratio to Buy Now

STRL, AXS, MOH & HALO's impressive interest coverage ratios highlight that these companies can withstand financial hardships.

Zacks | 7 months ago
AXIS Capital Stock Near 52-Week High: Is This Your Buy Signal?

AXIS Capital Stock Near 52-Week High: Is This Your Buy Signal?

AXS gains from a well-performing specialty insurance, reinsurance, as well as the accident and health portfolio.

Zacks | 7 months ago
Axis Capital Holdings Limited (AXS) Soars to 52-Week High, Time to Cash Out?

Axis Capital Holdings Limited (AXS) Soars to 52-Week High, Time to Cash Out?

Axis Capital (AXS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks | 7 months ago
Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns

Axsome Therapeutics Q1: Marketing-Driven Growth Masks Profitability Concerns

Axsome Therapeutics reported strong Q1 2025 earnings, with revenue and EPS beats driven by Auvelity and Sunosi, despite high SG&A expenses and net loss. Auvelity shows promising growth in the competitive depression market, but its success is heavily reliant on aggressive marketing and significant spending. Upcoming launches and regulatory submissions for Symbravo, AXS-14, AXS-05, and AXS-12 face stiff competition and potential regulatory hurdles.

Seekingalpha | 7 months ago
AXS or CB: Which Is the Better Value Stock Right Now?

AXS or CB: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Insurance - Property and Casualty sector have probably already heard of Axis Capital (AXS) and Chubb (CB). But which of these two stocks is more attractive to value investors?

Zacks | 7 months ago
Here's Why Axis Capital (AXS) is a Strong Value Stock

Here's Why Axis Capital (AXS) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 7 months ago
Should Value Investors Buy Axis Capital Holdings (AXS) Stock?

Should Value Investors Buy Axis Capital Holdings (AXS) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 7 months ago
AXIS Capital Holdings Limited (AXS) Q1 2025 Earnings Call Transcript

AXIS Capital Holdings Limited (AXS) Q1 2025 Earnings Call Transcript

AXIS Capital Holdings Limited (NYSE:AXS ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Cliff Gallant - Head, Investor Relations Vince Tizzio - President & Chief Executive Officer Pete Vogt - Chief Financial Officer Conference Call Participants Andrew Kligerman - TD Securities Christian Getzoff - Wells Fargo Meyer Shields - KBW Andrew Andersen - Jefferies Charlie Lederer - BMO Josh Shanker - Bank of America Operator Good day, and welcome to the First Quarter 2025 AXIS Capital Earnings Conference Call. All participants will be in listen-only mode.

Seekingalpha | 7 months ago
AXIS Capital Q1 Earnings Beat Estimates on Higher Investment Income

AXIS Capital Q1 Earnings Beat Estimates on Higher Investment Income

AXS' first-quarter results reflect solid underwriting income, improved investment income, and higher premiums across the segments, offset by escalating expenses.

Zacks | 7 months ago
Here's What Key Metrics Tell Us About Axis Capital (AXS) Q1 Earnings

Here's What Key Metrics Tell Us About Axis Capital (AXS) Q1 Earnings

While the top- and bottom-line numbers for Axis Capital (AXS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Zacks | 7 months ago
Loading...
Load More